Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

QANTM (QIP AU): Rouse Makes An Offer - But At What Price?

Qantm Weighs Rouse's And Adamantem's Proposals

Quiddity Advisors

Event-Driven

Qantm Intellectual Property / Event-Driven

<ul>
<li>It always seemed like a question of when, not if, <strong><a href="https://www.smartkarma.com/entities/iph-ltd" target="_blank" data-smartkarma-citation="entities:2495:1" rel="noopener">IPH (IPH AU)</a></strong> would make an Offer for <strong><a href="https://www.smartkarma.com/entities/qantm-intellectual-property" target="_blank" data-smartkarma-citation="entities:24317:1" rel="noopener">QANTM (QIP AU)</a></strong>. IPH previously approached QANTM in 2018, but was spurned.</li>
<li>Capitalising on ongoing extensions to Adamantem's exclusivity, as it relates to its all-cash A$1.817/share Offer by way of a Scheme, IPH has now tabled an all-scrip, plus A$0.11/share dividend <a href="https://announcements.asx.com.au/asxpdf/20240508/pdf/063c31fpygftp0.pdf" target="_blank" rel="noopener">NBIO</a>.</li>
<li>IPH's implied Scheme value of A$1.90/share is a premium to Adamantem's proposal. The catch: apart from terms being indicative, IPH's Offer requires ACCC and NZCC clearance.</li>
</ul>


It always seemed like a question of when, not if, IPH (IPH AU) would make an Offer for QANTM (QIP AU). IPH previously approached QANTM in 2018, but was spurned.
Capitalising on ongoing extensions to Adamantem's exclusivity, as it relates to its all-cash A$1.817/share Offer by way of a Scheme, IPH has now tabled an all-scrip, plus A$0.11/share dividend NBIO.
IPH's implied Scheme value of A$1.90/share is a premium to Adamantem's proposal. The catch: apart from terms being indicative, IPH's Offer requires ACCC and NZCC clearance.


QANTM (QIP AU): IPH Wades In As Adamantem Tarries